ChemBK
  • Home
  • Product Category
  • CHN
  1. Home
  2. CAS 2556646-63-8
  3. Supplier List
  4. MedChemExpress (MCE)
  5. Inhibitory Antibodies
  6. Visugromab

Request for quotation








Supplier Contact

Supplier NameMedChemExpress (MCE)
Contactsales
Tel609-228-6898
Mobile609-228-6898
QQ
Emailsales@medchemexpress.com; tech@medchemexpress.com
Websitehttps://www.medchemexpress.com/
Wechat
Product NameResearch Grade Visugromab (DHJ48302)
SynonymsResearch Grade Visugromab (DHJ48302)
CAS2556646-63-8
EINECS
Chemical Formula
Molecular Weight
inchi
Package1 mg;5 mg
PriceEmail to quote
DescriptionsVisugromab

Visugromab

MedChemExpress (MCE)

HY-P99100

2556646-63-8

CTL-002

98.40%

Please store the product under the recommended conditions in the Certificate of Analysis.

Shipping with dry ice.

Visugromab (CTL-002) is a GDF-15 neutralizing IgG4 mAb. Visugromab has synergistic anticancer activity with the anti-PD1 antibody Nivolumab (HY-P9903) and can effectively act on PD-1/PD-L1 relapsed/refractory metastatic solid tumors.

GDF-15 Clinical Trial

Chimeric

Descriptions

Visugromab

Visugromab

MedChemExpress (MCE)

HY-P99100

2556646-63-8

CTL-002

98.40%

Please store the product under the recommended conditions in the Certificate of Analysis.

Shipping with dry ice.

Visugromab (CTL-002) is a GDF-15 neutralizing IgG4 mAb. Visugromab has synergistic anticancer activity with the anti-PD1 antibody Nivolumab (HY-P9903) and can effectively act on PD-1/PD-L1 relapsed/refractory metastatic solid tumors.

GDF-15 Clinical Trial

Chimeric
Humanized

Human IgG4 kappa

Human IgG4 (S228P) kappa, Isotype Control

| | | |

| | | | | |



[1]. Necchi A, et al. Neutralizing GDF-15 in muscle-invasive bladder cancer (MIBC): A neoadjuvant immunotherapy trial of visugromab (CTL-002) in combination with the anti-PD1 antibody nivolumab (NEO-GDFATHER)[J]. 2023.

Last Update2025-04-01 14:45:47
MedChemExpress (MCE) also provides

Depatuxizumab

Category: Inhibitory Antibodies
CAS: 1471999-69-5
Last Update: 2025-04-01 14:45:47

Raxibacumab

Category: Inhibitory Antibodies
CAS: 565451-13-0
Last Update: 2025-04-01 14:45:47

Crizanlizumab

Category: Inhibitory Antibodies
CAS: 1690318-25-2
Last Update: 2025-04-01 14:45:47

Sofituzumab vedotin

Category: Inhibitory Antibodies
CAS: 1418200-58-4
Last Update: 2025-04-01 14:45:47

Fazpilodemab

Category: Inhibitory Antibodies
CAS: 2517935-02-1
Last Update: 2025-04-01 14:45:47

Osemitamab

Category: Inhibitory Antibodies
CAS: 2460539-61-9
Last Update: 2025-04-01 14:45:47

Vobramitamab

Category: Inhibitory Antibodies
CAS: 2490556-50-6
Last Update: 2025-04-01 14:45:47

Posdinemab

Category: Inhibitory Antibodies
CAS: 2517973-04-3
Last Update: 2025-04-01 14:45:47
  • Home
  • Product Category

© 2015 ChemBK.com All Rights Reserved | Build: 20150530002